BJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse

Similar documents
Wednesday, June 21, Dear Chairmen and Ranking Members:

Successful Prevention Strategies to Address the Opioid Crises

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

Data-Driven Prevention Initiative

SAMHSA FY 2017 Discretionary Grant Forecast

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

Collaborative for Effective Prescription Opioid Policies

Washington State PMP Data Mapping Project

Public Health Federal Funding Request to Address the Opioid Epidemic

Kansas Department of Health and Environment (KDHE) Kansas Data-Driven Prevention Initiative Request for Proposal (RFP) Fiscal Year 2019

Ops-Watch Weekly Grant Opportunities Update March 26 April 1, 2016

Vanila M Singh, MD MACM Chief Medical Officer Office of the Assistant Secretary for Health U.S. Department of Health and Human Services

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

CDC s Approach to Addressing the Opioid Overdose Epidemic

Assessing Opioid Misuse and Overdose Using Prescription Drug Monitoring Programs (PDMP) and Other Data Sources

National Strategies for Local Solutions

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2019 Budget and Appropriations

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

Partnerships for Success Grant Overview, Timelines and Questions

Data-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky

SAMHSA FY 2016 Discretionary Grant Forecast

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

Opportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives. Session 2

Coalition Strategies Across The Continuum of Care

From Medicaid Transformation Approved Project Toolkit, June 2017

HHSC LAR Request. Substance Abuse Disorder Coalition. Contact Person: Will Francis Members:

FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services

Opioid Response Package Awaits President s Signature Trinity Tomsic

1025 Connecticut Avenue NW, Suite 605 * Washington, DC * (202) * Fax: (202)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Meth and Opioid Abuse Prevention Efforts

Comprehensive Substance Abuse Strategic Action Plan

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Whatcom County. Opioid Abuse. Prevention & Response Plan

Strategies for Federal Agencies

ASTHO President s Challenge 15 x 15: Reduce Prescription Drug

SAMHSA Partnerships for Success Evaluation Plan Checklist

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

BJA Peer Recovery Support Services Mentor Initiative: Mentor Application

Community Engagement to Address the Opioid Crisis. Laura Palombi, PharmD, MPH, MAT, AE-C

FACT SHEET: Federal Parity Task Force Takes Steps to Strengthen Insurance Coverage for Mental Health and Substance Use Disorders

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

OPIOID WORKGROUP LEADERSHIP TEAM

CTAS FY 2018: Funding Opportunities for Healing to Wellness Courts February 6, 2018

OPIOID INITIATIVE SMART GOALS AND OBJECTIVES Four Pillar Approach

RX Drug Abuse Prevention in Nevada

Prescription Drug Abuse & Misuse: Neurobiology, Epidemiology, & EBPs

NCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Medicaid Transformation Project

Association of State and Territorial Health Officials (ASTHO)

SEOW Annual Report. Presented to SPF PFS Management. Report Timeframe: October 2015 September 2016

Michael M. Miller, MD, FASAM, FAPA

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

20% A Holistic Approach Built on Evidence OF U.S. ADULTS EXPERIENCE MENTAL ILLNESS EACH YEAR

SAMHSA: A Public Health Agency

Implementation of a Community-Wide Screening and Brief Intervention Project

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

SUMMIT ON REDUCING THE SUPPLY OF ILLEGAL OPIOIDS IN WASHINGTON. Legislative Action: Opportunities and Challenges June 16, 2017

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

The Opioid Addiction Crisis in the Northern Shenandoah Valley. A Community Response

Steve Daviss MD DFAPA Senior Medical Advisor Office of the Chief Medical Officer

Kansas Prescription Drug and Opioid Advisory Committee

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Program Evaluation for Prevention: Partnerships for Success

State Action to Prevent and

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

National Viral Hepatitis Action Plan Priority Populations Approach

Brockton Area Opioid Abuse Prevention Collaborative. Quick Guide

National Comprehensive Cancer Control Program Reviewer Training March 16, 2017

SAMHSA/HHS: An Update on the Opioid Crisis

Addressing Substance Use Disorder and the Opioid Epidemic in North Carolina

Preventing Opioid Misuse in Texas

Prescription Opioid Overdose in Oregon: A public health perspective

COMMUNITY ASSESSMENT OF THE OPIOID CRISIS IN LORAIN COUNTY, OHIO EXECUTIVE SUMMARY

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic

Bob Flewelling, PIRE Amy Livingston, PIRE Claudia Marieb, Vermont Dept. of Health Melanie Sheehan, Mt. Ascutney Hospital and Health Center

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Harold Rogers Update Melissa McPheeters, PhD, MPH

Opioid Crisis: HHS Strategy and Advancing Pain Management

Brockton Area Prevention Collaborative 30 Meadowbrook Road Brockton, MA

House Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515

American Academy of Pain Medicine American Pain Society American Society of Anesthesiologists

Taos Alive. Improving a Community in Pain By Julie Martinez CPS

Prescription Drug Abuse National Perspective

The Opioid Crisis Made in America Fade in America?

SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT ALLOCATION PLAN FEDERAL FISCAL YEAR 2012

PDSA Delaware: A Data and Logic Model Driven Prescription Drug and Substance Abuse Change Approach for Delaware

Heather L. Clinger, MPH, CPS Cathy Sisco, MPA, CPS Sara Wakai, PhD. August 2018 National Prevention Network Annual Conference

Overdose Fatality Review

Opportunities for Engaging Partners to Prevent Opioid Overdose-related Deaths

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

Behavioral Health Indicators Workgroup: Overview

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2019 Appropriations

Moving Towards a Continuum of Services. Plumas County Alcohol & Drug Strategic Planning Process DRAFT PLAN

2/20/2019. Source: Source:

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

Opioid Task Force Kick-Off Meeting. February 29, 2016

Transcription:

SAMHSA Programs to Address Prescription Drug Misuse and Abuse Jinhee Lee, PharmD Division of Pharmacologic Therapies Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration BJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse February 26, 2015

As we work to reduce substance abuse and the great damage it causes in our communities, we will make our country stronger and our people healthier and safer. President Barack Obama 3

SAMHSA s Programs Align with National Strategies & Fills Gaps SAMHSA s programs align with national strategies and metrics; are designed to complement the efforts of stakeholders and partners; and are intended to fill gaps in national, state, and local efforts. 4

Substance Abuse Prevention and Treatment Block Grants In 1981, Congress approved a new mechanism, the Block Grants (BG), as a way to provide assistance to States, Territories, and other local governing units that provide public MH/SUD services. BGs have an inherent flexibility so that individual localities can address the unique needs of their citizenry. This flexibility is balanced with statutory spending and reporting requirements designed to ensure public accountability, transparency, and return-oninvestment. 5

SABG Targeted Populations and Service Areas Pregnant women and women with dependent children Intravenous drug users Tuberculosis services Early intervention services for HIV/AIDS Primary prevention services 6

SAMHSA Block Grant Applications Two types of BGs are administered by SAMHSA: SABG MHBG Block Grant Applications are tripartite: 1) Behavioral Health Assessment & Plan ( Plan ) 2) BG Report 3) Synar Report A BG application is considered complete and fundable only after all 3 parts of the application have been submitted & approved. 7

SABG Block Grant Applications Submission options: Submit a separate SABG Plan Submit a single, combined SABG/MHBG Plan Combined submission maintains the integrity of the 2 different BGs, but streamlines the application process for states. For FY2012/2013 plans, 22 states and 2 jurisdictions submitted combined SABG/MHBG Plans. 8

SABG Application Timeline Behavioral Health Assessment & Plans are submitted biennially. SABG Reports are submitted annually. Synar Reports are submitted annually. Applications for SABG funds are submitted annually. The request for FY2015 funds is a separate, miniapplication (i.e., funding agreements & certifications; planned expenditures; & 2 planned expenditures checklists). 9

Strategic Prevention Framework Partnerships for Success State and Tribal Initiative The SPF-PFS program is designed to address one or both of the following substance abuse prevention priorities underage drinking among persons aged 12 to 20; a prescription drug misuse and abuse among persons aged 12 to 25. At their discretion, states/tribes may also use SPF- PFS funds to target an additional, data-driven prevention priority (e.g., marijuana, heroin) in their state/tribe. Slide 10

SPF-PFS Grantee Expectations Grantees are expected to work with their State/Tribal Epidemiological Outcome Workgroups (SEOWs) to identify their selected sub-recipient communities, document their identified needs and prevention priority(ies), and identify why these communities were selected over other high-need communities in the state/tribe. Grantees expected to explain how they will leverage, redirect, and/or realign prevention funds and resources (including SABG) to support SPF-PFS goals Slide 11

SPF-PFS Award Information RFA Number: SP-15-003 Application Due Date: Friday, 3/16/2015 Anticipated Total Available Funding:$28 million Anticipated Number of Awards: up to 38 Anticipated Award Amount: From $318,543 to $2,472,608 per year Length of Project: Up to 5 years Program Contact Person: Tonia Gray at tonia.gray@samhsa.hhs.gov Website: http://www.samhsa.gov/grants/grantannouncements/sp-15-003 Slide 12

Drug-Free Communities Support Program The DFC Program was created by the Drug-Free Communities Act of 1997 (Public Law 105-20). The DFC Support Program has two goals: Establish and strengthen collaboration among communities, public and private non-profit agencies; as well as federal, state, local, and tribal governments to support the efforts of community coalitions working to prevent and reduce substance use among youth*. Reduce substance use among youth and, over time, reduce substance abuse among adults by addressing the factors in a community that increase the risk of substance abuse and promoting the factors that minimize the risk of substance abuse. *For the purposes of this RFA, youth is defined as individuals 18 years of age and younger. Slide 13

Drug-Free Communities Support RFA Number: SP-15-001 Program Application Due Date: Wednesday, 3/18/2015 Anticipated Total Available Funding:$21, 250,000 Anticipated Number of Awards: ~ 170 Anticipated Award Amount: Up to $125,000 per year Length of Project: Up to 5 years Program Contact Person: Virginia Simmons at virginia.simmons@samhsa.hhs.gov Website: http://www.samhsa.gov/grants/grantannouncements/sp-15-001 Slide 14

Grants to Expand Substance Abuse Treatment Capacity in Adult and Family Drug Courts Purpose: To expand and/or enhance substance abuse treatment services in existing adult and family problem solving courts, which use the treatment drug court model in order to provide alcohol and drug treatment to defendants/offenders. Application Due Date: Friday, March 27, 2015 RFA Number: TI-15-002, http://www.samhsa.gov/grants/grantannouncements/ti-15-002 Anticipated Total Available Funding: $11,300,000 Anticipated Number of Awards: Up to 35 Anticipated Award Amount: Up to $325,000 Length of Project: Up to 3 years Contact Person: Gregory Torain at Gregory.torain@samhsa.hhs.gov Slide 15

SAMHSA Treatment Drug Courts Grant Expectations Grantees will be expected to provide a coordinated, multisystem approach designed to combine the sanctioning power of treatment drug courts with effective treatment services to break the cycle of criminal behavior, child abuse and neglect, alcohol and/or drug use, and incarceration or other penalties. Grants funds must be used to serve people diagnosed with a substance use disorder as their primary condition, particularly high risk/high need populations diagnosed with substance dependence or addiction to alcohol/other drugs and identified as needing immediate treatment. Slide 16

SAMHSA Treatment Drug Courts Grant Expectations Grant funds must be used to address gaps in the continuum of treatment for those individuals in these drug courts who have substance abuse and/or co-occurring disorders treatment needs. Grant funds may be used to provide services for comorbid conditions, such as mental health problems, as long as expenditures remain consistent with the drug court model which is designed to serve individuals needing treatment for substance dependence or addiction to alcohol/other drugs. Grant funds may be used to provide services for co-morbid conditions, such as mental health problems, as long as expenditures remain consistent with the drug court model which is designed to serve individuals needing treatment for substance dependence or addiction to alcohol/other drugs Slide 17

Targeted Capacity Expansion: Medication Assisted Treatment Prescription Drug and Opioid Addiction Purpose: Expand access to MAT services for persons with opioid use disorder. Award Size: $11 million Anticipated Number of Awards: Up to 11 Anticipated Award Amount: Up to $1 million Length of Project: Up to 3 years RFA posting date: February 26, 2015 Application due date: May 8, 2015 SAMHSA contact: Dr. Anthony Campbell at tony.campbell@samhsa.hhs.gov 18

SAMHSA TCE-MAT Grant Expectations The purpose of this program is to provide funding to states to enhance/expand their treatment service systems to increase capacity and provide accessible, effective, comprehensive, coordinated care, and evidencebased MAT and recovery support services to individuals with opioid use disorders seeking or receiving MAT. As a result of this program, SAMHSA seeks to: 1) increase the number of individuals receiving MAT services with pharmacotherapies approved by the FDA for the treatment of opioid use disorders; 2) increase the number of individuals receiving integrated care; and 3) decrease illicit drug use at 6-months follow-up. Priority will be given to states that have not only demonstrated a high rate of primary treatment admissions for heroin and opioids per capita, but that have also demonstrated a dramatic increase in hospital admissions in recent years. For more information please go to http://www.samhsa.gov/grants/grantannouncements/ti-15-007. Slide 19

CDC Prescription Drug Overdose Prevention for States Cooperative Agreement The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to conduct policy evaluations or implement other prescribing innovations. Slide 20

CDC Prescription Drug Overdose Prevention for States Cooperative Agreement Estimated Post Date: Early March 2015 Estimated Application Due Date: Early May Estimated Funding: $55,600,000 Estimated Award Ceiling: $1,000,000 Estimated Award Floor: $750,000 http://www.acf.hhs.gov/hhsgrantsforecast/in dex.cfm?switch=grant.view&gff_grants_forec astinfoid=100000439 Slide 21

Thank you! Jinhee Lee, PharmD jinhee.lee@samhsa.hhs.gov The findings and conclusions in this report are those of the author and do not necessarily represent the views of the Substance Abuse and Mental Health Services Administration. Slide 22